ANGIOTENSINOGEN GENE DELETION IN RENAL TUBULES AMERIOLATES TUBULOPATHY VIA ATTENUATION OF MITOCHONDRIAL DYSFUNCTION AND SENESCENCE IN DIABETIC KIDNEY DISEASE

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 


 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
 
ANGIOTENSINOGEN GENE DELETION IN RENAL TUBULES AMERIOLATES TUBULOPATHY VIA ATTENUATION OF MITOCHONDRIAL DYSFUNCTION AND SENESCENCE IN DIABETIC KIDNEY DISEASE

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
John
Chan
John Chan john.chan@umontreal.ca Universite de Montreal CRCHUM Montreal Canada *
Wen-Xia Yang wenxia.yang@umontreal.ca Universite de Montreal CRCHUM Montreal Canada -
Min-Chun Liao michenliaw@gmail.ca Universite de Montreal CRCHUM Montreal Canada -
Junzheng Peng junzheng.peng.chum@ssss.gouv.qc.ca Universite de Montreal CRCHUM Montreal Canada -
Michifumi Yamashita michifumi.yamashita@csmc.edu Cedars-Sinai Medical Center Pathology and Lab. Medicine Los Angeles United States -
Kana Miyata kana.miyata@health.slu.edu Saint Louis University Internal Medicine-Nephrology Saint Louis United States -
Janos Filep janos.g.filep@umontreal.ca Universite de Montreal Maisonneuve-Rosement Hospital-Research Centre Montreal Canada -
Julie Ingelfinger jingelfinger@nejm.org Massachusetts General Hospital Pediatric Nephrology Unit Boston United States -
Shao-Ling Zhang shao.ling.zhang@umontreal.ca Universite de Montreal CRCHUM Montreal Canada -
 
 
 
 
 
 

We reported that renal tubule (RT) angiotensinogen (Agt) gene deletion attenuates glomerular hyperfiltration, tubular injury, SGLT2 expression in renal proximal tubules (RPTs) and decreases urinary albumin-creatinine ratio (uACR) of T1D Akita mice (Diabetes 2025).  The present study was aimed to explore the molecular mechanisms underlying tubulopathy in diabetes. 

Male non-diabetic control, RT-Agt  knockout (KO), Akita, and Akita RT-Agt KO mice at 42 weeks old, HK-2 (human immortalized proximal tubule cell line) and MDCK (Madin-Darby Canine Kidney) cells were studied. Tubular cell size, luminal area, interstitial fibrosis, apoptosis, mitochondrial oxidative stress and function, senescence (senescence-associated β-galactosidase (SA β-Gal)) and senescence-associated secretory phenotype (SASP) were assessed.  

Akita mice exhibited significant increases in tubular cell size, luminal area, renal dihydroethidium (DHE) and 8-Hydroxy-2’-deoxyguanosine (8-OHdG) staining, uACR, apoptosis, expression of NADPH Oxidase 4 (NOX4), transforming growth factor-beta 1 (TGF-β1), monocyte chemoattractant protein-1 (MCP-1) and fibronectin, disruption of mitochondrial cristae (electronic microscopy analysis), SA β-Gal activity, SASP gene (Ccl2, Cxcl1 and Tnf-α) expression, and immunofluorescent staining of p16 in distal tubules. These abnormalities were markedly attenuated in Akita RT-Agt- KO mice. Culture of HK2 cells with high glucose (HG) (35 mM D-glucose) and Ang II (10-7 M) triggered NOX4-mediated mitochondrial oxidative stress (MitoSox staining), reduced mitochondrial transmembrane potential (JC1 staining), disrupted mitochondrial morphology (Mitotracker assay), increased p16 expression, SA β-Gal activity and SASP gene expression in HK-2 cells. These changes were attenuated by losartan (an AT1R blocker) or apocynin (an NOX4 inhibitor). Furthermore, addition of Ang II/HG-induced senescent MDCK-derived conditioned medium to HK-2 cells facilitated the epithelial-to-mesenchymal transition in HK2 cells, which was reversed by losartan or apocynin treatment.

Deletion of Agt in RT attenuates tubulopathy, at least in part, through lessening ROS-mediated DNA damage, mitochondrial dysfunction and senescence in Akita mice. Parts of the data, will be presented at the Annual Meeting of the American Society of Nephrology, Houston, TX, USA, November 5-9, 2025. 

Kewords